Department of the Navy August 24, 2006 – Federal Register Recent Federal Regulation Documents

The Department of the Navy hereby gives notice of its intent to grant to Tessarae Inc., a revocable, non-assignable, exclusive license to practice in the field of use defined as design process, systems and applications utilizing high-density resequencing microarrays (greater than 100,000 features per array and less than 500 square micron feature size), and manufacturable under good practice standards in batch quantities greater than 1,000 arrays (such as CustomSeq resequencing microarrays fabricated by Affymetrix, Inc.), for screening, diagnosis where approved by the appropriate local government health authority, and/or surveillance of pathogen induced disease in the U.S. and certain foreign countries, the Government-owned inventions described in Navy Case No. 96,744: COMPUTER-IMPLEMENTED BIOLOGICAL SEQUENCE IDENTIFIER SYSTEM AND METHOD.//Navy Case No. 97,439: BROAD- SPECTRUM PATHOGEN DIAGNOSTIC AND SURVEILLANCE SYSTEM.//Navy Case No. 97,747: AUTOMATED SAMPLE-TO-MICROARRAY SYSTEM.//Navy Case No. 97,748: OPTIMIZED PATHOGEN RESEQUENCING DIAGNOSTIC AND SURVEILLANCE SYSTEM.// Navy Case No. 98,057: RAPID DETECTION FOR OVER 20 RESPIRATORY PATHOGENS SIMULTANEOUSLY IN CLINICAL SAMPLES USING RESEQUENCING ARRAYS AND ANY CONTINUATIONS, DIVISIONALS OR RE-ISSUES THEREOF.